Vascular calcification in CKD: New insights into its mechanisms
Journal of Cellular Physiology · 2023-06 · 238 (6) · 1160-1182
DOI: 10.1002/jcp.31021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 03.06.2023. Verfasst von Nannan Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Vascular Calcification, Hyperphosphatemia, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 185 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Vascular calcification (VC) is a common complication of chronic kidney disease (CKD) and contributes to an increased risk of cardiovascular morbidity and mortality. However, effective therapies are still unavailable at present. It has been well established that VC associated with CKD is not a passive process of calcium phosphate deposition, but an actively regulated and cell‐mediated process that shares many similarities with bone formation. Additionally, numerous studies have suggested that CKD patients have specific risk factors and contributors to the development of VC, such as hyperphosphatemia, uremic toxins, oxidative stress and inflammation. Although research efforts in the past decade have greatly improved our knowledge of the multiple factors and mechanisms involved in CKD‐related VC, many questions remain unanswered. Moreover, studies from the past decade have demonstrated that epigenetic modifications abnormalities, such as DNA methylation, histone modifications and noncoding RNAs, play an important role in the regulation of VC. This review seeks to provide an overview of the pathophysiological and molecular mechanisms of VC associated with CKD, mainly focusing on the involvement of epigenetic modifications in the initiation and progression of uremic VC, with the aim to develop promising therapies for CKD‐related cardiovascular events in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Neurology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
- Department of Nephrology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
- Department of Pathology, Shandong University, Jinan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ding, N., Lv, Y., Su, H., Wang, Z., Kong, X., Zhen, J., Lv, Z., & Wang, R. (2023). Vascular calcification in CKD: New insights into its mechanisms. Journal of Cellular Physiology, 238(6), 1160-1182. https://doi.org/10.1002/jcp.31021
Vancouver
Ding N, Lv Y, Su H, Wang Z, Kong X, Zhen J, et al. Vascular calcification in CKD: New insights into its mechanisms. Journal of Cellular Physiology. 2023;238(6):1160-1182. doi:10.1002/jcp.31021
BibTeX
@article{Ding2023,
author = {Ding, Nannan and Lv, Yaodong and Su, Hong and Wang, Ziyang and Kong, Xianglei and Zhen, Junhui and Lv, Zhimei and Wang, Rong},
title = {Vascular calcification in CKD: New insights into its mechanisms},
journal = {Journal of Cellular Physiology},
year = {2023},
volume = {238},
number = {6},
pages = {1160--1182},
doi = {10.1002/jcp.31021}
}
EUVIMED